Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
49 participants
INTERVENTIONAL
2022-01-01
2023-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Iodine Status After Intake of Sushi and Seaweed Salad
NCT05773456
Seaweed Iodine Delivered Via Food or Supplementation
NCT04875377
Age Related Effects Consuming Phaeodactylum Tricornutum
NCT05120791
Seaweed, the Food Matrix, and Iodine Bioavailability
NCT04867291
Pilot Study to Evaluate the Effect of Two Microalgae Consumption on Metabolic Syndrome
NCT05343858
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study will provide new insight into the status of iodine, cadmium, and inorganic arsenic that macroalgae consumers have in urine and thyroid function after regular macroalgae consumption and after cessation of macroalgae intake. In addition, the study will provide descriptive data on macroalgae consumption, how it is eaten, how often, and how much. This can provide critical knowledge to the national and European authorities for food safety and public health advisers to evaluate the food safety of macroalgae.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
CROSSOVER
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Usual macroalgae consumption
Crossover design with habitual macroalgae consumption at baseline
Habitual macroalgae consumption
The participant have a habitual macroalgae consumption at baseline.
No macroalgae consumption
The participants exclude any macroalgae products from their diet
Cessation of macroalgae consumption
Cessation of macroalgae consumption as an experimental intervention.
Habitual macroalgae consumption
The participant have a habitual macroalgae consumption at baseline.
No macroalgae consumption
The participants exclude any macroalgae products from their diet
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Habitual macroalgae consumption
The participant have a habitual macroalgae consumption at baseline.
No macroalgae consumption
The participants exclude any macroalgae products from their diet
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* weekly consumer of macroalgae
Exclusion Criteria
* known disease
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institute of Marine Research
OTHER
University of Bergen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Inger Aakre, PhD
Role: PRINCIPAL_INVESTIGATOR
Institute of Marine Research
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Bergen
Bergen, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
332865
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.